Search Results - "Hendriks, A E J"

Fertility and Ovarian Function in High-Dose Estrogen-Treated Tall Women by Hendriks, A. E. J, Laven, J. S. E, Valkenburg, O, Fong, S. Lie, Fauser, B. C. J. M, de Ridder, M. A. J, de Jong, F. H, Visser, J. A, van Ginneken, A. M, Boot, A. M, Drop, S. L. S

“…High-dose estrogen-treated tall women are at risk of subfertility in later life; treated women exhibit signs of accelerated ovarian ageing with concomitant…”
Get full text

Fertility of Tall Girls Treated with High-Dose Estrogen, a Dose-Response Relationship by Hendriks, A. E. J, Drop, S. L. S, Laven, J. S. E, Boot, A. M

“…Context: High-dose estrogen treatment to reduce final height of tall girls increases their risk for infertility in later life. Objective: The aim was to study…”
Get full text

Fatherhood in Tall Men Treated with High-Dose Sex Steroids during Adolescence by Hendriks, A. E. J, Boellaard, W. P. A, van Casteren, N. J, Romijn, J. C, de Jong, F. H, Boot, A. M, Drop, S. L. S

“…Background/Objective: Sex steroid treatment to reduce final height of tall boys has been available since the 1950s. In women, it has been shown to interfere…”
Get full text

Fertility potential in men with a history of congenital undescended testes: a long‐term follow‐up study by Brakel, J., Kranse, R., Muinck Keizer‐Schrama, S. M. P. F., Hendriks, A. E. J., Jong, F. H., Bangma, C. H., Hazebroek, F. W. J., Dohle, G. R.

“…Men with a history of congenital undescended testes (UDT) have an increased risk of fertility problems. Despite no definitive proof, current guidelines…”
Get full text

Genetic variation in candidate genes like the HMGA2 gene in the extremely tall by Hendriks, A E J, Brown, M R, Boot, A M, Oostra, B A, Drop, S L S, Parks, J S

“…Genetic variation in several candidate genes has been associated with short stature. Recently, a high-mobility group A2 (HMGA2) gene SNP has been robustly…”
Get more information

Fertility of Tall Girls Treated With High-Dose Estrogen, A Dose-Response Relationship by Hendriks, A. E J, Drop, S. L S, Laven, J. S E, Boot, A M

“…High-dose estrogen treatment has been widely used to reduce the adult final height of tall girls. Women treated in childhood with high-dose estrogen are at…”
Get full text

Genetic and epigenetic variability in the gene for IGFBP-3 ( IGFBP3 ): Correlation with serum IGFBP-3 levels and growth in short children born small for gestational age by Kaay, D.C.M. van der, Hendriks, A.E.J, Ester, W.A, Leunissen, R.W.J, Willemsen, R.H, Kort, S.W.K. de, Paquette, J.R, Hokken-Koelega, A.C.S, Deal, C.L

“…Abstract Context IGF-I and IGFBP-3 play a central role in fetal and postnatal growth and levels are low in short SGA children. The -202 A/C and -185 C/T SNPs…”
Get full text

Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects by Hendriks, A.E.J, Brown, M.R, Boot, A.M, Oostra, B.A, de Jong, F.H, Drop, S.L.S, Parks, J.S

“…Abstract Context/objective The growth hormone (GH)/insulin-like growth factor-1(IGF-1) axis is the key regulator of somatic growth in humans and its genes are…”
Get full text

Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes by Hendriks, A. Emile J., Marcovecchio, M. Loredana, Besser, Rachel E. J., Bonifacio, Ezio, Casteels, Kristina, Elding Larsson, Helena, Gemulla, Gita, Lundgren, Markus, Kordonouri, Olga, Mallone, Roberto, Pociot, Flemming, Szypowska, Agnieszka, Toppari, Jorma, Ziegler, Anette G., Mathieu, Chantal, Achenbach, Peter, Mathieu, C., Gillard, P., Casteels, K., Overbergh, L., Wallace, C., Evans, M., Thankamony, A., Hendriks, A. E. J., Bruggraber, S., Marcovecchio, M. L., Peakman, M., Tree, T., Richardson, S., Todd, J., Wicker, L., Mander, A., Dayan, C., Alhadj Ali, M., Pieber, T., Eizirik, D., Cnop, M., Brunak, S., Pociot, F., Johannesen, J., Rossing, P., Legido Quigley, C., Mallone, R., Scharfmann, R., Boitard, C., Knip, M., Otonkoski, T., Lahesmaa, R., Oresic, M., Toppari, J., Danne, T., Ziegler, A. G., Achenbach, P., Rodriguez‐Calvo, T., Solimena, M., Bonifacio, E., Speier, S., Holl, R., Dotta, F., Chiarelli, F., Marchetti, P., Bosi, E., Cianfarani, S., Ciampalini, P., Beaufort, C., Dahl‐Jørgensen, K., Skrivarhaug, T., Krogvold, L., Jarosz‐Chobot, P., Battelino, T., Thorens, B., Roep, B., Nikolic, T., Zaldumbide, A., Lernmark, A., Costecalde, G., Strube, T., Schulte, A., Nitsche, A., Peakman, M., Vela, J., Herrath, M., Wesley, J., Napolitano‐Rosen, A., Thomas, M., Schloot, N., Goldfine, A., Waldron‐Lynch, F., Kompa, J., Vedala, A., Hartmann, N., Nicolas, G., Rampelbergh, J., Bovy, N., Dutta, S., Soderberg, J., Ahmed, S., Martin, F., Latres, E., Koralova, A.

“…Background/Aim Type 1 diabetes is an autoimmune disease that involves the development of autoantibodies against pancreatic islet beta‐cell antigens, preceding…”
Get full text